Suppr超能文献

慢性神经性疼痛机制的研究进展

Research progress on the mechanism of chronic neuropathic pain.

作者信息

Cui Cai-Xia, Liu Hong-Yu, Yue Na, Du Yi-Ri, Che Li-Muge, Yu Jian-She

机构信息

Inner Mongolia Medical University, Hohhot, China.

Department of Anesthesiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

出版信息

IBRO Neurosci Rep. 2022 Dec 20;14:80-85. doi: 10.1016/j.ibneur.2022.12.007. eCollection 2023 Jun.

Abstract

Chronic neuropathic pain (CNP) refers to pain that lasts for more than three months due to a disease or an injury to the somatosensory nervous system. The incidence of CNP has been increasing in the world, causing it to become a global concern and patients often experience spontaneous pain, hyperalgesia, abnormal pain or even abnormal sensation as some of its main symptoms. In addition to serious pain and poor physical health, CNP also negatively affects patients' mental health, thus impacting the overall quality of their lives. The pathogenesis of CNP is not clear, but some studies have proved that central sensitization, peripheral sensitization, neuroinflammation, dysfunction in descending nociceptive modulatory systems, oxidative stress reaction, activation of glial cells and psychological factors play an important role in the occurrence and development of CNP. In this context, this article summarizes the current research progress on the mechanism of CNP to provide a basis for further research in preventing and treating the disease.

摘要

慢性神经性疼痛(CNP)是指由于躯体感觉神经系统的疾病或损伤而持续超过三个月的疼痛。CNP在全球的发病率一直在上升,已成为一个全球性问题,患者常出现自发痛、痛觉过敏、异常性疼痛甚至感觉异常等主要症状。除了严重疼痛和身体健康不佳外,CNP还对患者的心理健康产生负面影响,从而影响其整体生活质量。CNP的发病机制尚不清楚,但一些研究证明,中枢敏化、外周敏化、神经炎症、下行伤害性调制系统功能障碍、氧化应激反应、胶质细胞激活和心理因素在CNP的发生和发展中起重要作用。在此背景下,本文总结了目前关于CNP机制的研究进展,为该疾病的进一步防治研究提供依据。

相似文献

1
Research progress on the mechanism of chronic neuropathic pain.
IBRO Neurosci Rep. 2022 Dec 20;14:80-85. doi: 10.1016/j.ibneur.2022.12.007. eCollection 2023 Jun.
2
Neuroinflammation Involved in Diabetes-Related Pain and Itch.
Front Pharmacol. 2022 Jun 20;13:921612. doi: 10.3389/fphar.2022.921612. eCollection 2022.
4
Elucidation of pathophysiology and treatment of neuropathic pain.
Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645.
5
Corneal Neuropathic Pain: A Patient and Physician Perspective.
Ophthalmol Ther. 2024 Apr;13(4):1041-1050. doi: 10.1007/s40123-024-00897-z. Epub 2024 Feb 16.
6
Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury.
Pain. 2019 Dec;160(12):2724-2742. doi: 10.1097/j.pain.0000000000001670.
7
Differential pain modulation properties in central neuropathic pain after spinal cord injury.
Pain. 2016 Jul;157(7):1415-1424. doi: 10.1097/j.pain.0000000000000532.
9
Pain responsiveness to opioids: central versus peripheral neuropathic pain.
J Opioid Manag. 2011 Sep-Oct;7(5):391-400. doi: 10.5055/jom.2011.0080.
10
Glycometabolism Reprogramming of Glial Cells in Central Nervous System: Novel Target for Neuropathic Pain.
Front Immunol. 2022 May 20;13:861290. doi: 10.3389/fimmu.2022.861290. eCollection 2022.

引用本文的文献

2
Clinical Phenotypes of Diabetic Peripheral Neuropathy: Implications for Phenotypic-Based Therapeutics Strategies.
Diabetes Metab J. 2025 Jul;49(4):542-564. doi: 10.4093/dmj.2025.0299. Epub 2025 Jul 1.
3
Opiorphin and neuropathic pain: a promising treatment approach?
Inflammopharmacology. 2025 Jul 3. doi: 10.1007/s10787-025-01827-6.
6
Neuro-Nutritional Approach to Neuropathic Pain Management: A Critical Review.
Nutrients. 2025 Apr 29;17(9):1502. doi: 10.3390/nu17091502.
7
Environmental enrichment for neuropathic pain via modulation of neuroinflammation.
Front Mol Neurosci. 2025 Mar 21;18:1547647. doi: 10.3389/fnmol.2025.1547647. eCollection 2025.
8
NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities.
Curr Issues Mol Biol. 2025 Jan 31;47(2):93. doi: 10.3390/cimb47020093.
10
The Influence of Anesthesia on Neuromonitoring During Scoliosis Surgery: A Systematic Review.
NeuroSci. 2024 Dec 17;5(4):693-712. doi: 10.3390/neurosci5040049.

本文引用的文献

1
Spinal Cord Stimulation and Treatment of Peripheral or Central Neuropathic Pain: Mechanisms and Clinical Application.
Neural Plast. 2021 Oct 21;2021:5607898. doi: 10.1155/2021/5607898. eCollection 2021.
2
Higenamine Attenuates Neuropathic Pain by Inhibition of NOX2/ROS/TRP/P38 Mitogen-Activated Protein Kinase/NF-ĸB Signaling Pathway.
Front Pharmacol. 2021 Sep 24;12:716684. doi: 10.3389/fphar.2021.716684. eCollection 2021.
3
4
Usual presence and intensity of pain are differentially associated with suicidality across chronic pain conditions: A population-based study.
J Psychosom Res. 2021 Sep;148:110557. doi: 10.1016/j.jpsychores.2021.110557. Epub 2021 Jun 28.
7
Chronic pain: an update on burden, best practices, and new advances.
Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7.
9
A central mechanism of analgesia in mice and humans lacking the sodium channel Na1.7.
Neuron. 2021 May 5;109(9):1497-1512.e6. doi: 10.1016/j.neuron.2021.03.012. Epub 2021 Apr 5.
10
The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studies.
Pharmacol Ther. 2021 Sep;225:107846. doi: 10.1016/j.pharmthera.2021.107846. Epub 2021 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验